RECENT ADVANCES IN CANCER IMMUNOTHERAPY
Immunotherapy has tremendous potential for treatment of cancer in dogs. Clinical trials of antibody therapeutics in human oncology have demonstrated remarkable results in inducing tumor regressions and cures against a variety of cancer types.
This presentation will focus on the current status and research in the area of cancer immunotherapy for dogs. Discussion will include:
-
Major immune targets for new cancer immunotherapies
-
Strategies for generating effective cancer immunity
-
How we can repurpose existing drugs as cancer immunotherapies
-
Updates on recent cancer immunotherapy trials
Original Air Date: Wednesday, May 13, 2020
Speaker: Steven Dow, DVM, PhD, Diplomate ACVIM (Oncology)
Watch on Demand
Learn more about Dr. Dow’s CHF-funded research:
Grant 02487: OX40 Checkpoint Molecule Targeted Antibodies for Cancer Immunotherapy in Dogs
Grant 01472: Enhanced Killing of Malignant Histiocytosis with a Novel Combination of Anti-Tumor Drugs
Grant 01152: Liposomal Bisphosphonate Therapy for Malignant Histiocytosis
Grant 00778: Role of Regulatory T Cells in Dogs with Osteosarcoma
Related Articles
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
